Adalimumab is a biologic agent used in RA. Which option lists this drug in the correct position?

Study for the MCC Block 2 Test. Enhance your skills with interactive quizzes featuring hints and explanations. Prepare effectively and excel in your exam!

Multiple Choice

Adalimumab is a biologic agent used in RA. Which option lists this drug in the correct position?

Explanation:
Biologic therapies in rheumatoid arthritis target specific parts of the immune system to slow joint damage. Adalimumab is a monoclonal antibody that binds TNF-alpha, blocking its inflammatory signals and reducing joint inflammation. This makes it a biologic disease-modifying antirheumatic drug. In contrast, methotrexate is a traditional DMARD, celecoxib is a COX-2–selective NSAID used for pain and inflammation, and prednisone is a corticosteroid. Among these, Adalimumab stands out as the biologic agent used in RA.

Biologic therapies in rheumatoid arthritis target specific parts of the immune system to slow joint damage. Adalimumab is a monoclonal antibody that binds TNF-alpha, blocking its inflammatory signals and reducing joint inflammation. This makes it a biologic disease-modifying antirheumatic drug. In contrast, methotrexate is a traditional DMARD, celecoxib is a COX-2–selective NSAID used for pain and inflammation, and prednisone is a corticosteroid. Among these, Adalimumab stands out as the biologic agent used in RA.

More practice questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy